earli
march
outbreak
sar
occur
princ
wale
hospit
teach
hospit
chines
univers
hong
kong
studi
particip
patient
admit
hospit
suspect
sar
first
week
outbreak
patient
fulfil
world
health
organ
definit
probabl
sar
case
briefli
patient
acut
onset
fever
chill
rigor
dyspnea
myalgia
headach
hypoxemia
peripher
airspac
consolid
subsequ
develop
studi
patient
observ
chest
radiograph
thorac
comput
tomograph
scan
patient
show
respons
antimicrobi
drug
prescrib
typic
atyp
pneumonia
macrolid
fluoroquinolon
studi
examin
patient
compris
first
group
sar
patient
clear
histori
exposur
fortyf
particip
adult
men
women
year
age
mean
year
age
standard
deviat
year
group
includ
healthcar
worker
medic
student
work
ward
index
ward
hospit
patient
sar
stay
remain
patient
hospit
visitor
ward
three
studi
particip
children
two
boy
one
girl
year
age
children
live
person
hospit
visitor
index
ward
contract
sar
nasopharyng
aspir
npa
sampl
taken
patient
insert
suction
cathet
nasopharyng
area
via
nostril
low
suction
forc
appli
collect
approxim
ml
fluid
transfer
ml
viral
transport
medium
npa
ad
onto
rhesu
monkey
kidney
human
laryng
carcinoma
mardin
darbi
canin
kidney
mdck
human
embryon
lung
fibroblast
buffalo
green
monkey
kidney
bgm
african
green
monkey
kidney
vero
monolay
cell
cultur
incub
except
mdck
incub
npa
ad
addit
cell
cultur
tube
incub
cell
monolay
examin
daili
cytopath
effect
day
incub
hemadsorpt
test
mdck
monolay
perform
cell
cultur
materi
kept
frozen
subsequ
analys
detect
hmpv
use
nest
rtpcr
focus
fgene
rtpcr
appli
cell
cultur
regardless
cytopath
effect
one
cycl
freezeandthaw
rna
extract
cell
cultur
use
qiaamp
viral
rna
mini
kit
qiagen
gmbh
hilden
germani
accord
manufactur
protocol
outer
primer
tgt
tcc
att
ggc
agc
rt
amplif
ctg
ttc
rcc
ytc
aac
r
g
c
amplif
primer
design
basi
hmpv
sequenc
avail
genbank
reaction
carri
singletub
superscript
onestep
rtpcr
platinum
taq
invitrogen
corp
carlsbad
ca
use
primer
thermal
cycl
condit
min
min
follow
cycl
final
extens
min
second
round
amplif
use
inner
primer
tag
gga
tca
tca
agc
tag
ctg
rta
tac
agt
pcr
conduct
min
denatur
dna
templat
activ
hotstart
dna
polymeras
hotstartaq
qiagen
gmbh
follow
cycl
final
extens
min
pcr
product
detect
agaros
gel
electrophoresi
analyz
sequenc
homolog
known
hmpv
strain
addit
viru
isol
rna
extract
directli
npa
hmpv
rtpcr
use
protocol
cell
cultur
rna
extract
supernat
vero
cell
cultur
show
cytopath
effect
use
method
hmpv
coronaviru
detect
rtpcr
primer
sens
cac
cgt
ttc
tac
agg
tta
gct
aac
ga
antisens
aaa
tgt
tta
cgc
agg
taa
gcg
taa
aa
shown
specif
novel
coronaviru
detect
patient
sar
rtpcr
coronaviru
conduct
similarli
hmpv
use
primer
thermal
cycl
condit
min
min
cycl
min
nucleotid
sequenc
purifi
pcr
product
determin
pcrbase
cycl
sequenc
perform
inner
primer
sequenc
reaction
perform
accord
manufactur
protocol
bigdy
termin
cycl
sequenc
kit
version
appli
biosystem
foster
citi
ca
run
abi
prism
genet
analyz
sequenc
confirm
repeat
pcr
sequenc
direct
select
cell
cultur
show
cytopath
effect
examin
electron
microscopi
cell
cultur
supernat
coat
formvarcarbon
grid
stain
phosphotungst
acid
ascertain
hmpv
cultur
result
obtain
pair
serum
sampl
first
sampl
collect
within
day
second
sampl
collect
day
onset
ill
test
hmpv
antibodi
cell
coat
glass
slide
fix
aceton
presenc
antibodi
serum
sampl
test
use
direct
immunofluoresc
techniqu
specimen
process
viral
cultur
inocul
rna
extract
rtpcr
amplif
pcr
product
analys
conduct
differ
room
special
care
taken
avoid
contamin
rnase
avoid
crosscontamin
reaction
inocul
cell
monolay
place
neg
control
use
cell
line
inject
mainten
medium
everi
fifth
cell
cultur
tube
neg
control
cell
cultur
tube
also
incub
examin
cytopath
effect
process
rtpcr
cell
cultur
tube
inject
specimen
rna
extract
rtpcr
procedur
place
neg
control
use
cell
cultur
medium
replac
cell
supernat
inject
npa
doubl
distil
water
replac
npa
sampl
everi
fifth
reaction
neg
control
show
posit
result
indic
absenc
crosscontamin
test
reproduc
rtpcr
result
repeat
test
posit
sampl
randomli
select
neg
sampl
result
reproduc
also
spike
neg
npa
sampl
hmpv
rna
repeat
extract
rtpcr
procedur
result
show
inhibitor
present
extract
rna
prepar
npa
studi
observ
cytopath
effect
mdck
human
embryon
lung
fibroblast
bgm
monolay
eleven
specimen
show
cytopath
effect
diffus
refractil
round
cell
vero
cell
monolay
day
incub
progress
rapidli
involv
whole
monolay
within
hour
cytopath
effect
reproduc
passag
vero
cell
appear
day
incub
vero
cell
cultur
posit
coronaviru
rtpcr
vero
cell
cultur
supernat
show
cytopath
effect
randomli
select
electron
microscopi
examin
coronaviru
particl
seen
five
specimen
show
cytopath
effect
focal
refractil
round
cell
monolay
cell
cultur
incub
unlik
cytopath
effect
observ
vero
cell
attribut
coronaviru
cytopath
effect
develop
day
incub
progress
slowli
detach
cell
monolay
hmpv
rtpcr
examin
cell
cultur
neg
human
embryon
lung
fibroblast
bgm
cell
vero
cell
includ
posit
coronaviru
contrast
hmpv
rtpcr
show
pcr
product
expect
size
bp
isol
materi
inject
specimen
nucleotid
sequenc
pcr
product
ident
fgene
fragment
hmpv
genbank
access
nc
retrospect
examin
first
round
pcr
product
posit
sampl
posit
sampl
deriv
direct
npa
show
posit
band
indic
nest
rtpcr
necessari
howev
deriv
cell
cultur
show
posit
band
expect
size
first
round
pcr
distribut
hmpv
rtpcr
result
direct
detect
npa
differ
cell
cultur
type
shown
tabl
overal
sensit
direct
detect
npa
use
hmpv
rtpcr
sampl
one
two
sampl
isol
viru
three
cell
line
sampl
isol
viru
overal
sensit
cell
line
hmpv
posit
sampl
cell
detect
sampl
mdck
cell
detect
sampl
except
three
sampl
show
posit
result
cell
six
cell
cultur
posit
hmpv
incub
three
posit
cultur
correspond
cell
cultur
incub
show
posit
result
ascertain
cell
cultur
hmpv
result
repres
isol
hmpv
incub
mdck
cell
cultur
regardless
hmpv
rtpcr
find
passag
cell
prolong
incub
day
cell
use
purpos
cell
monolay
often
difficult
maintain
week
result
show
passag
hmpv
cell
cultur
show
cytopath
effect
focal
refractil
round
cell
occur
day
incub
figur
cytopath
effect
progress
slowli
detach
cell
monolay
figur
supernat
passag
also
posit
hmpv
rtpcr
visibl
hmpv
viral
particl
electron
microscopi
examin
figur
passag
hmpv
supernat
show
posit
result
test
also
passag
five
vero
cell
cultur
posit
coronaviru
cell
similar
way
passag
show
cytopath
effect
neg
hmpv
rtpcr
reconfirm
fact
hmpv
infect
detect
combin
approach
repres
genuin
infect
coat
hmpvinfect
cell
onto
slide
antibodi
detect
use
immunofluoresc
techniqu
hmpv
patient
serolog
evid
infect
fourfold
rise
antibodi
titer
patient
seroconvert
overal
result
indic
combin
approach
use
convent
viru
isol
molecular
detect
could
success
appli
isol
hmpv
figur
approach
found
among
studi
particip
hmpv
coronaviru
isol
npa
hmpv
coronaviru
eighteen
viru
isol
cell
line
use
basi
combin
convent
viru
isol
system
molecular
techniqu
found
patient
sar
admit
hospit
hmpv
infect
isol
hmpv
known
difficult
viru
could
detect
recent
first
report
hmpv
van
den
hoogen
et
al
show
viru
produc
syncytia
format
tertiari
monkey
kidney
cell
follow
rapid
intern
disrupt
cell
subsequ
detach
cell
monolay
viru
replic
poorli
vero
cell
human
lung
adenocarcinoma
cell
could
propag
mdck
cell
chicken
embryo
fibroblast
studi
boivin
et
al
multipl
cell
line
includ
mdck
human
foreskin
fibroblast
vero
mink
lung
human
rhabdomyosarcoma
rd
transform
human
kidney
human
colon
adenocarcinoma
use
isol
hmpv
result
show
hmpv
grew
cell
cytopath
effect
round
refring
cell
without
syncytia
format
case
observ
agreement
result
studi
cell
monolay
show
cytopath
effect
sinc
cell
test
hmpv
rna
know
whether
find
cell
also
observ
boivin
et
al
anoth
studi
report
peret
et
al
mdck
cell
use
research
found
cell
produc
cytopath
effect
focal
round
without
syncytia
format
also
similar
observ
major
differ
approach
hmpv
isol
compar
previou
studi
use
rtpcr
enhanc
detect
hmpv
isol
cell
cultur
approach
found
cell
wide
avail
commonli
use
cell
line
support
growth
hmpv
rtpcr
use
follow
cell
cultur
sensit
cell
higher
cell
cell
line
commonli
use
previou
studi
hmpv
howev
even
use
approach
cell
discard
case
hmpv
isol
cell
contrast
presenc
cell
mdck
cell
gave
littl
addit
valu
specimen
posit
mdck
cell
virus
isol
cell
addit
initi
incub
day
might
optim
isol
hmpv
boivin
et
al
report
cytopath
effect
took
mean
incub
time
day
develop
prolong
initi
incub
cell
day
hmpv
infect
might
detect
neg
group
studi
sampl
collect
patient
relat
outbreak
sar
occur
hospit
one
simpli
infer
vitro
growth
properti
appli
hmpv
strain
gener
nevertheless
approach
includ
cell
wide
avail
cell
line
search
hmpv
particular
case
relat
sar
need
consid
studi
six
patient
coinfect
hmpv
coronaviru
although
number
limit
find
suggest
hmpv
coronaviru
differ
vitro
tropism
isol
one
viru
affect
recoveri
differ
cell
line
overal
confirm
patient
admit
hospit
sar
hmpv
infect
also
coinfect
coronaviru
howev
data
high
preval
hmpv
interpret
cautious
studi
popul
base
person
famili
member
expos
index
ward
hospit
thu
cocircul
two
pathogen
within
studi
group
possibl
clinic
present
studi
particip
fulfil
world
health
organ
definit
probabl
case
sar
one
infer
stage
preval
hmpv
similarli
high
sar
outbreak
occur
elsewher
hand
possibl
import
role
hmpv
current
worldwid
outbreak
sar
neglect
hmpv
also
detect
five
six
sar
patient
live
canada
studi
seri
coronaviru
also
detect
five
six
patient
four
patient
coinfect
hmpv
coronaviru
recent
studi
implic
strong
associ
novel
coronaviru
worldwid
outbreak
sar
hmpv
coronaviru
infect
may
result
sever
respiratori
tract
diseas
transmiss
effici
may
urgent
question
must
answer
answer
affect
prioriti
immedi
develop
control
strategi
outbreak
sar
appli
combin
approach
convent
viru
isol
molecular
detect
establish
viral
infect
statu
patient
hospit
sar
process
analyz
larger
cohort
elucid
clinic
condit
treatment
respons
epidemiolog
link
respect
infect
statu
hmpv
coronaviru
similar
work
part
world
need
